Vimarsana
Biggest News Aggregation in the World

Page 32 - Human Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Use Today - Breaking & Trending Today

Vertex Pharmaceuticals Cystic Fibrosis Drug Gets Positive Opinion in EU For Treatment in Infants - Vimarsana News

Vertex Pharmaceuticals Cystic Fibrosis Drug Gets Positive Opinion in EU For Treatment in Infants

By Adriano Marchese Vertex Pharmaceuticals said Friday that its treatment for cystic fibrosis was given a positive opinion by European Union regulators to treat infants with specific mutations...

Merck: positive CHMP opinion for Keytruda in NSCLC -February 23, 2024 at 08:36 am EST - Vimarsana News

Merck: positive CHMP opinion for Keytruda in NSCLC -February 23, 2024 at 08:36 am EST

Merck announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has given a positive opinion recommending the approval of Keytruda + platinum-based...

Merck Says Keytruda Combination Gets Positive EU CHMP Opinion As Neoadjuvant Treatment For NSCLC - Vimarsana News

Merck Says Keytruda Combination Gets Positive EU CHMP Opinion As Neoadjuvant Treatment For NSCLC

Drug major Merck & Co., Inc. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP adopted a positive opinion recommending approval of its anti-PD-1 therapy KEYTRUDA, in combination with platinum-containing chemotherapy.

Bristol Myers: positive CHMP opinion in anemia -February 23, 2024 at 08:08 am EST - Vimarsana News

Bristol Myers: positive CHMP opinion in anemia -February 23, 2024 at 08:08 am EST

Bristol Myers Squibb announces that it has received a positive opinion from the CHMP for Reblozyl in the treatment of adults with transfusion-dependent anemia due to low- to intermediate-risk...

Bristol Myers Gets CHMP Backing for Expanded Reblozyl Use - Vimarsana News

Bristol Myers Gets CHMP Backing for Expanded Reblozyl Use

By Colin Kellaher Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of its anemia drug Reblozyl. The...